Summary
HHS issued an RFI, led by the Office of the Deputy Secretary and ASTP/ONC, seeking public input on how the Department can accelerate adoption and use of AI as part of clinical care. The notice asks stakeholders to describe promising AI use cases, barriers to adoption, and concrete actions HHS should take across regulation, reimbursement, health IT policy, and research and development to enable safe, effective, and trustworthy AI in care delivery.
Healthcare Implications
The RFI signals a coordinated, cross-HHS effort to reshape the national policy environment for clinical AI. Depending on subsequent actions, it could lead to changes in FDA oversight of AI-enabled devices, CMS payment policy, ONC health IT requirements, and federal research priorities. HHS presented preliminary takeaways from the completed comment process in June 2026.